Stamford, CT -- (SBWIRE) -- 01/07/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Organovo Holdings Inc (NYSEMKT:ONVO), Sarepta Therapeutics Inc (NASDAQ:SRPT), Apple Inc. (NASDAQ:AAPL), Penn Virginia Corporation (NYSE:PVA)
Organovo Holdings Inc (NYSEMKT:ONVO) opened the session at $10.80, trading in a range of $9.86 - $10.90. The stock showed a negative performance of -6.61% in the last trading session from its previous close of $1.90 and closed at $10.18. The stock traded on a volume of 4.40 million shares and the average volume of the stock remained 4.88 million shares. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
Has ONVO Found The Bottom and Ready To Move Up? Find Out Here
Sarepta Therapeutics Inc (NASDAQ:SRPT) traded 4.23 million shares in the last business day while the average volume of the stock remained 1.81 million shares. The stock showed a negative movement of -8.17% to end at $18.77. The 52 week range of the stock remained $12.12 - $55.61. Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy.
Has SRPT Found The Bottom And Ready To Gain Momentum? Find Out Here
Apple Inc. (NASDAQ:AAPL) reported 14.76 million shares were exchanged during the last trade, while the average volume is about 11.52 million shares. The stock escalated +0.55% and finished the day at $543.93. The beta of the stock is recorded at 0.84. Apple Inc. and its wholly-owned subsidiaries design, manufacture, and market mobile communication and media devices, personal computers, and portable digital music players worldwide. It also sells software, services, peripherals, networking solutions, and third-party digital content and applications related to its products.
For How Long AAPL’s Gloss will Attract Investors? Find out via this report
Penn Virginia Corporation (NYSE:PVA) shares rose, +8.00 percent from its previous close of $9.12 to close at $9.85. Traded with volume of 4.31 million shares in the prior session and the average volume of the stock remained 2.54 million shares. Penn Virginia Corporation, an independent oil and gas company, engages in the exploration and development of natural gas and oil properties in various onshore regions of the United States. The company is involved in the production and sale of natural gas, crude oil, and natural gas liquid products. It primarily focuses on developing the Eagle Ford Shale play in south Texas.
Why Should Investors Buy PVA After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)